These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27215925)

  • 1. Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.
    Liu X; Wang Y
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):359-70. PubMed ID: 27215925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.
    Bach T; An G
    J Pharmacokinet Pharmacodyn; 2021 Aug; 48(4):581-595. PubMed ID: 33884580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.
    Bauer RJ; Guzy S; Ng C
    AAPS J; 2007 Mar; 9(1):E60-83. PubMed ID: 17408237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of different population pharmacokinetic algorithms.
    Colucci P; Grenier J; Yue CS; Turgeon J; Ducharme MP
    Ther Drug Monit; 2011 Oct; 33(5):583-91. PubMed ID: 21912327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
    Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
    BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of uncertainty parameters estimated by different population PK software and methods.
    Dartois C; Lemenuel-Diot A; Laveille C; Tranchand B; Tod M; Girard P
    J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):289-311. PubMed ID: 17216368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.
    Plan EL; Maloney A; Mentré F; Karlsson MO; Bertrand J
    AAPS J; 2012 Sep; 14(3):420-32. PubMed ID: 22528503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM
    Sukarnjanaset W; Wattanavijitkul T; Jarurattanasirikul S
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):729-736. PubMed ID: 29785609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension of the SAEM algorithm for nonlinear mixed models with 2 levels of random effects.
    Panhard X; Samson A
    Biostatistics; 2009 Jan; 10(1):121-35. PubMed ID: 18583352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to handling pharmacodynamic baseline responses.
    Dansirikul C; Silber HE; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):269-83. PubMed ID: 18446428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.
    Hooker AC; Staatz CE; Karlsson MO
    Pharm Res; 2007 Dec; 24(12):2187-97. PubMed ID: 17612795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations.
    Ozdin D; Sharma N; Lujan-Zilbermann J; Colucci P; Kanfer I; Ducharme MP
    J Pharm Pharm Sci; 2018; 21(1):413-428. PubMed ID: 30407906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the glucose minimal model by stochastic nonlinear-mixed effects methods.
    Largajolli A; Bertoldo A; Cobelli C
    Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():5482-5. PubMed ID: 23367170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study.
    Mak WY; Ooi QX; Cruz CV; Looi I; Yuen KH; Standing JF
    Br J Clin Pharmacol; 2023 Jan; 89(1):330-339. PubMed ID: 35976674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the nonparametric estimation method in NONMEM VI.
    Savic RM; Kjellsson MC; Karlsson MO
    Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREME.
    Yates JW
    Comput Methods Programs Biomed; 2009 Oct; 96(1):49-62. PubMed ID: 19410328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics.
    Mentré F; Gomeni R
    J Biopharm Stat; 1995 Jul; 5(2):141-58. PubMed ID: 7581424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The estimation of population pharmacokinetic parameters using an EM algorithm.
    Aarons L
    Comput Methods Programs Biomed; 1993 Sep; 41(1):9-16. PubMed ID: 8275683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.